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The Structural Dynamics of Alpha-Tropomyosin on F-Actin Shape the
Overlap Complex between Adjacent Tropomyosin Molecules
William Lehman1, Xiaochuan Li1, Marek Orzechowski1, Stefan Fischer2.
1Boston University School Medicine, Boston, MA, USA, 2University of
Heidelberg, Heidelberg, Germany.
Coiled-coil tropomyosin, localized on actin filaments in virtually all eukary-
otic cells, serves as a gatekeeper regulating access of the motor protein
myosin and other actin-binding proteins onto the thin filament surface. In
order to form a continuous cable on thin filaments that is free of gaps, adjacent
tropomyosin molecules polymerize head-to-tail by means of a short (~9-10
residue) overlap. Thus to characterize the overlap structure, several labora-
tories have engineered peptides to mimic the N/C-terminal tropomyosin
association. The overlapping domains formed show a compact N-terminal
coiled-coil inserting into a partially opened C-terminal partner, where the
opposing coiled-coils at the overlap junction face each other at up to ~90
twist angles. Here, Molecular Dynamics simulations were carried out to deter-
mine constraints on the formation of the tropomyosin overlap complex and to
assess the amount of twisting exhibited by full-length tropomyosin when
bound to actin. With the exception of the last 20 to 40 C- and N-terminal
residues, we find that the average tropomyosin structure closely resembles a
"canonical" model proposed in the classic work of McLachlan and Stewart,
displaying perfectly symmetrical supercoil geometry matching theF-actin he-
lix with an integral number of coiled-coil turns, a coiled-coil helical pitch of
137 A˚, a superhelical pitch of 770 A˚, and no localized pseudo-rotation. Over
the middle 70% of tropomyosin, the average twisting of the coiled-coil devi-
ates only by 10 from the canonical model and the torsional freedom is very
small (std. dev. of 7). This small degree of twisting cannot yield the orthog-
onal N- and C-termini configuration observed experimentally. However, in
marked contrast, considerable coiled-coil unfolding, splaying and twisting
at N- and C-terminal ends is observed, providing the conformational plasticity
needed for head-to-tail nexus formation.
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Myosin Binding to Human Cardiac Thin Filaments Containing
Tropomyosin Carrying DCM & HCM Mutations; Fitting of Complex
Binding Transients
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Myosin S1 binds to pyrene labelled thin filaments in a calcium dependent
manner. When mixing an excess of S1 with thin filaments at low calcium the
transient is complex in form and requires a complete model of the regulated
binding to fit the data. Using the recently published Monte Carlo version of
the Mckillop & Geeves model (REF) we have now fitted a complete set of cal-
cium dependent myosin binding transients to thin filaments containing WT hu-
man tropomyosin with human cardiac troponin. In addition we have analysed
the data for 5 tropomyosin mutations carrying HCM (E175N, & E180G) or
DCM mutations (E54K , E40K and D230N) in one or both Tm chains of the
dimer. All transients can be well described by the model and for each case
the calcium dependent data can be described by a single set of parameters
with a change only in the apparent value and calcium dependence of KB (the
equilibrium constant between the blocked and closed states of the filament)
small secondary effects may be present in value of KT ( equilibrium between
closed and open states). For the HCM mutations the value of KB showed
enhanced calcium sensitivity with little change in the value of KB at high
and low calcium. In contrast, preliminary data for DCMmutations showed little
change in the calcium dependence of KB, but larger changes in the low calcium
value of KB. This could mean that the DCMmutations turn off the thin filament
more effectively. All other constants remain unchanged within experimental
error.
Supported by the Welcome Trust, NIH R01 AR048776 and Serbian Ministry of
Science grants III41007 and OI174028.
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Mg2D Dependent Modulation of Striated Muscle Myosin ATPase by Thin
Filament Components
Minae Kobayashi, Ben Ramirez.
University of Illinois at Chicago, Chicago, IL, USA.
While it’s been reported that non-muscle myosin such as myosin V can be
regulated by Mg2þ, striated muscle myosin modulation by Mg2þ-concentra-tion dependency, especially in relation to thin filament components, has not
been well studied up to now. It has been suggested that ADP release (product
release) from myosin V is affected by Mg2þ concentration. Therefore, Mg2þ-
dependent modulation of striated muscle myosin ATPase was explored in the
presence of reconstituted muscle thin filament components, i.e. actin, tropo-
myosin and troponin. ATPase activity assays and Nuclear Magnetic Reso-
nance (NMR) spectroscopy were employed to understand the mechanisms
of ATP hydrolysis by striated muscle myosin and the role of Mg2þ in the
enzymatic activity. An NMR technique called Water Ligand-Observed
Gradient Spectroscopy (WaterLOGSY) was utilized to probe if the interaction
of myosin with ADP (one of the products resulted from ATP hydrolysis) is
different depending on Mg2þ concentration as well as the presence of muscle
thin filament components. Our WaterLOGSY data demonstrated that this
technique is a promising method to monitor ADP binding to myosin head
S1 even in the presence of actin filaments and that there was a change in
the appearance of peaks between with and without tropomyosin at a low
Mg2þ concentration. This set of results indicates that the way by which
myosin binds ADP is different depending on the states of thin filaments.
Moreover, actomyosin S1 ATPase rate decreased as Mg2þ concentration
increased. When tropomyosin was reconstituted in the thin filaments, the
ATPase rate decreased more rapidly compared with actomyosin alone. Thus
we conclude that Mg2þ plays an important role in striated muscle myosin
ATPase and that regulatory components such as tropomyosin modulate
Mg2þ dependency of myosin ATPase in the striated muscle.
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Kinetic and Structural Characterization of Calcium Sensitizer Action on
Thin Filament Function using FRET
William D. Schlecht, Wenji Dong, King Lun Li.
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The use of novel calcium sensitizing agents in the treatment of heart disease
offers therapeutic value for patients suffering from a particularly prevalent
and recalcitrant condition, however the elusive mechanisms of action for these
drugs prevent increased and improved utilization of such agents clinically.
Ideally the calcium sensitizer impact on the thin filament could be monitored
directly in a physiologically relevant and dynamic way while still capturing
the molecular level mechanisms involved. With that aim a homo-FRET scheme
was developed which monitors the N-domain opening of the calcium binding
subunit of cardiac troponin (N-cTnC) by labeling with TAMRA at
cTnC(cys-13) and cTnC(cys-51). Using this novel FRET design the calcium
binding properties of reconstituted troponin and their deactivation kinetics
were measured in the presence of calcium sensitizers Levosimendan, Bepridil,
Pimobendan, and EMD-57033 at various levels of in vitro reconstitution. We
hypothesized that depending on the mechanism for each calcium sensitizer
the effects on cTnC calcium binding and deactivation kinetics would vary
based on the level of reconstitution. We expect that new insight into which
thin filament proteins are necessary for sensitizer action will yield a clearer pic-
ture of the molecular level mechanisms underlying cardiotonic action.
Although the study is currently ongoing preliminary results show significant
sensitization for all four drugs in reconstituted ternary troponin compared to
control and that this effect is abrogated in samples containing only cTnC and
cardiac troponin inhibitory subunit (cTnI). Deactivation kinetics show a
decreased transition rate for Levosimendan, Bepridil and Pimobendan but
not for EMD-57033 both at the ternary troponin level and at the cTnI-cTnC
level. Results from measurements with reconstituted thin filament preparation
will be also discussed.
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During cardiac thin filament activation, the N-domain of Ca2þ-binding car-
diac troponin C (N-cTnC) interacts with the actomyosin inhibitory troponin
I (cTnI) subunit, which concomitantly opens the cTnC N-domain and leads to
force generation. Recently, we used in situ steady state FRET measurements
based on N-cTnC opening to determine that strongly bound cross-bridges
(XBs) stabilize this Ca2þ-sensitizing N-cTnC-cTnI interaction. However,
the method was unable to determine how N-cTnC opening is affected by
770a Wednesday, February 19, 2014sarcomere length (SL). In this study, we used time-resolved in situ FRET to
monitor the effects of Ca2þ-occupancy, XB state, and SL on N-cTnC open-
ing in skinned cardiac muscle fibers. FRET donor (AEDANS) and acceptor
(DDPM) modified double-cysteine mutant cTnC(13C/51C)AEDANS-DDPM
was reconstituted into skinned muscle fibers to examine the N domain of
cTnC (N-cTnC) opening. To study the effect of SL on structural transitions
of cTnC, we monitored the protein structural transitions at low and high
[Ca2þ] and SL 1.8 and 2.2 mm. Mg2þ-ADP and sodium orthovanadate (Vi)
were used to examine the effects of non-cyclng strong and weak XBs,
respectively. We found that strongly bound XBs alter structural transitions
of cardiac troponin only at 2.2 mm. On the other hand, Vi blunted the SL
dependent opening of N-cTnC such that weak XBs have no effect on
N-cTnC at either [Ca2þ] or SL. In addition, distance distribution analysis
indicated that N-cTnC adopts four unique conformations associated with
the four states of thin filament regulation, and that N-cTnC conformational
equilibria are caused by cycling XBs. Based on our findings, we conclude
that the observed dependence of myosin positive feedback regulation on
SL is an important determinant of the Frank-Starling law of the heart.
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Ca2D-Regulatory Function of the Inhibitory Peptide Region of Cardiac
Troponin I is Aided by the C-Terminus of Cardiac Troponin T: Effects
of FHC Mutations Ctni R145G and Ctnt R278C, Alone and in Combina-
tion, on Filament Sliding
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P. Bryant Chase6.
1Biology, Barry University, Miami Shores, FL, USA, 2Institute of Molecular
Biophysics, Florida State University, Tallahassee, FL, USA, 3Department of
Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA,
4HGST,, San Jose Research Center, San Jose, CA, USA, 5Department of
Physics, Florida State University, Tallahassee, FL, USA, 6Institute of
Molecular Biophysics and Department of Biological Science, Florida State
University, Tallahassee, FL, USA.
Investigations of cardiomyopathy mutations in Ca2þ regulatory proteins
troponin and tropomyosin provide crucial information about cardiac disease
mechanisms, and provide insights into functional domains in the affected
polypeptides. Hypertrophic cardiomyopathy-associated mutations TnI
R145G, located within the inhibitory peptide (Ip) of human cardiac troponin
I (hcTnI), and TnT R278C, located immediately C-terminal to the IT arm
in human cardiac troponin T (hcTnT), share remarkable features: structurally,
biochemically, and pathologically. Using bioinformatics, we find compelling
evidence that affected regions of hcTnI and hcTnT, may be related_not just
structurally_but also evolutionarily. Because alignment of TnI and TnT coin-
cides with the known structure of the IT-arm, and both Arg mutations are
located close to the C-terminal end of the IT-arm, we investigated functional
relationships between hcTnI R145G and hcTnT R278C. We hypothesized that
if the mutations affected function independently, then their effects would be
additive in a double mutant complex. We characterized Tn complexes con-
taining either mutation alone, or both mutations simultaneously, using in vitro
motility assays run with varying [Ca2þ], temperature, or HMM density. Our
most significant findings show that TnT R278C "rescued" some deleterious
effects of TnI R145G at high Ca2þ, but exacerbated the loss of function
(i.e., switching off the actomyosin interaction) at low Ca2þ. Taken together,
our results raise the likelihood that cTnI’s Ip sequence might share a common
evolutionary origin with, and thus be structurally and functionally related to,
the C-terminus of cTnT. In accord with this prediction, our experimental re-
sults suggest that the C-terminus of cTnT aids Ca2þ-regulatory function of
cTnI Ip within the troponin complex.
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Impact of Troponin-I Phosphorylation on Human Cardiac Myofilament
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A long-term goal of work in our laboratories is to understand the structural ba-
sis of myofilament function, i.e. cross-bridge dynamics (CD) and myofilament
length dependent activation (LDA) in striated muscle in heath and disease.
Moreover, in cardiac muscle LDA underlies the Frank Starling Law of the
Heart. Troponin phosphorylation, and in particular troponin-I (cTnI), has
been suggested to be a pivotal modulator of myofilament function. Here weexamined the impact of phosphorylation of distinct cTnI domains on CD and
LDA in isolated human myocardium. Site specific phosphorylation was accom-
plished by charge mutation of hcTnI phosphomimics on the PKA (S23/24D),
PKC (S42/44E; T143E), AMPK (S150D), and novel (S5/6D) sites, followed
by recombinant protein exchange into skinned non-failing human LV cardiac
muscle strips (~2mm long, and ~150um diameter. Force and ATPase activity
was measured as function of [Ca2þ] at short and long sarcomere length
(SL=2.0&2.3um). We found, LDA: hcTnI-S150D attenuated, hcTnI-S42/43E
increase, and no effect for the other sites. CD as indexed by tension cost
was: decreased for cTnI-S42/44E and hcTnI-S150D, and no effect for the other
sites. We conclude that cTnI phosphorylation at distinct sites differentially
affect cross-bridge cycling and length dependent activation in human myocar-
dium. Structural analysis employing x-ray diffraction is underway to determine
the structural basis for these phenomena. Supported by NIH HL075494,
HL62426, GM103622.
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The R144W Mutation in Mouse Cardiac Troponin T Attenuates Cross-
bridge Recruitment and Detachment Kinetics
Sampath K. Gollapudi, Murali Chandra.
Department of IPN, Washington State University, Pullman, WA, USA.
A missense mutation, R141W, in the strong tropomyosin-binding region of
human cardiac troponin T (cTnT) is associated with dilated cardiomyopathy
(DCM). Previous studies of steady-state contractile function suggest that
DCM-related mutations in cTnT attenuate myofilament Ca2þ sensitivity.
Steady-state observations by themselves may not be sufficient enough to
provide a reliable link between different mutations and divergent cardiac phe-
notypes, especially at submaximal Ca2þ levels. It is now widely appreciated
that dynamic relationships - rather than steady-state aspects of the force-pCa
relationship - dominate in conditions under which cardiac muscle functions.
To understand the effects of the R141W mutation on cardiac contractile
dynamics, we created a mouse cTnT analog (McTnTR144W) of the human mu-
tation, R141W. McTnTR144W and the wild-type McTnT were individually re-
constituted into detergent-skinned mouse cardiac muscle fibers and dynamic
contractile features were assessed at maximal (pCa 4.3) and submaximal (pCa
5.5) activations. McTnTR144W-reconstituted fibers revealed the following.
The speed of crossbridge (XB) recruitment, b, decreased significantly at
both pCa 4.3 and pCa 5.5; however, the magnitude of decrease was 2-fold
greater at submaximal activation. The speed of XB detachment dynamics,
c, also decreased and was 1.7-fold greater at submaximal activation. How-
ever, the XB strain-mediated effects on the recruitment of other XBs (g) -
mediated by allosteric/cooperative mechanisms operating within the thin
filament - decreased to a similar extent at both Ca2þ activations. Novel find-
ings from our study will be discussed in terms of the McTnTR144W-induced
effects on the thin filament cooperativity and its associations with slower
rates of XB recruitment and detachment kinetics at physiologically relevant
Ca2þ concentrations.
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Effects of Pseudophosphorylation of Rat Cardiac Troponin T Residue 204
are Differently Affected by a- and b-Myosin Heavy Chain Isoforms
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We tested our hypothesis that a-myosin heavy chain (MHC) and b-MHC
differently modulate the functional effects of protein kinase C (PKC)-medi-
ated phosphorylation of rat cardiac troponin T (RcTnT). We generated a
chimeric pseudophosphorylated RcTnT in which the threonine 204 was
replaced by glutamic acid (cTnTT204E) to mimic the PKC-mediated phos-
phorylation effect. Recombinant proteins were reconstituted into detergent-
skinned cardiac muscle fibers from normal rats expressing a-MHC or
propylthiouracil-treated rats expressing b-MHC. Steady state measurements
revealed that Ca2þ-activated maximal tension and the corresponding ATPase
activity decreased significantly by ~75% in a-MHCþcTnTT204E fibers, but
only by ~33% in b-MHCþcTnTT204E fibers. However, the myofilament
Ca2þ sensitivity (pCa50) decreased by ~50% in both a-MHCþcTnTT204E
and b-MHCþcTnTT204E fibers, suggesting that the greater decrease in
maximal tension observed in a-MHCþcTnTT204E fibers cannot be merely
attributed to the decrease in Ca2þ-mediated activation of thin filaments. Inter-
estingly, the rates of tension redevelopment (ktr), crossbridge (XB) recruit-
ment dynamics (b), XB distortion dynamics (c), and the tension cost
(ATPase rate/tension) decreased only in a-MHCþcTnTT204E fibers. Our re-
sults demonstrate that a- and b-MHC isoforms have different impact on
